Company Filing History:
1 out of 112 
1 out of 37 
1 out of 5,094 
Years Active: 2011-2016
Title: The Innovative Mind of Benoit Polack
Introduction
Benoit Polack, an accomplished inventor based in Saint Martin le Vinoux, France, has made significant contributions to the field of pharmaceutical innovation. With a total of two patents to his name, Polack's work primarily focuses on developing treatments for hemophilia and advanced protein production methods.
Latest Patents
One of Polack's most notable patents is the "Procoagulant Molecular Decoy for Treating Hemophilia A or B with or without Inhibitor." This invention pertains to a pharmaceutical composition that includes a modified factor Xa (GDXa), which is designed to be nonthrombogenic and capable of binding to TFPI without interacting with phospholipids. This composition aims to either prevent or treat hemorrhagic accidents in patients suffering from hemophilia A or B, with or without inhibitors.
The second patent, titled "Tool for the Transfer and Production of Proteins Using the Pseudomonas Type III Secretion System," provides a vector for the expression of a chimeric protein. This protein results from the fusion of the N-terminal end of ExoS with an amino acid sequence of interest, thereby aiding in the effective production of proteins for research and therapeutic applications.
Career Highlights
Benoit Polack has been associated with highly esteemed institutions, including Université Joseph Fourier and Université Joseph Fourier-Grenoble 1. His work in these organizations has further enriched his expertise as an innovative researcher and inventor in the field of pharmaceuticals.
Collaborations
Throughout his career, Polack has collaborated with notable individuals such as Bertrand Toussaint and Lauriane Quenee. These collaborations highlight the importance of teamwork in driving innovations and fostering advancements in science and technology.
Conclusion
Benoit Polack stands out as a significant figure in the realm of pharmaceutical inventions, particularly in addressing critical medical issues like hemophilia. His contributions through innovative patents not only reflect his expertise but also promise future advancements in treatment modalities that can impact countless lives.